PUBLISHER: The Business Research Company | PRODUCT CODE: 1947108
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947108
Self-expanding stents are medical devices engineered to open and uphold the patency (openness) of narrowed or obstructed blood vessels or tubular structures within the body. Constructed from flexible materials, often metal alloys such as nitinol, these stents possess the characteristic of self-expansion upon deployment in the body. The objective of self-expanding stents is to address various medical conditions characterized by the narrowing or occlusion of blood vessels or other tubular structures.
The primary types of self-expanding stents include gastrointestinal self-expanding stents, carotid self-expanding stents, endovascular self-expandable stents, and others. Gastrointestinal self-expanding stents are medical devices utilized for treating narrowings or blockages in the digestive tract, as they expand and provide support to the affected area. They find applications in various settings such as fem-pop artery stents, iliac artery stents, carotid artery stents, biliary stents, and others. End users of these stents include hospitals, ambulatory surgical centers, and other healthcare facilities.
Tariffs are influencing the self-expanding stents market by increasing costs of imported nitinol alloys, precision manufacturing equipment, coating materials, and delivery system components. Hospitals and device manufacturers in North America and Europe are most affected due to dependence on specialized material imports, while Asia-Pacific faces export-related pricing pressures. These tariffs are increasing device prices and impacting procurement budgets. However, they are also encouraging localized stent manufacturing, regional material sourcing, and innovation in alternative alloy and production technologies.
The self-expanding stents market research report is one of a series of new reports from The Business Research Company that provides self-expanding stents market statistics, including self-expanding stents industry global market size, regional shares, competitors with a self-expanding stents market share, detailed self-expanding stents market segments, market trends and opportunities, and any further data you may need to thrive in the self-expanding stents industry. This self-expanding stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The self-expanding stents market size has grown strongly in recent years. It will grow from $3.49 billion in 2025 to $3.69 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, expansion of interventional cardiology procedures, advancements in stent materials, growing adoption of endovascular therapies, rising hospital catheterization lab volumes.
The self-expanding stents market size is expected to see steady growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive treatments, expansion of peripheral artery disease management, growing focus on durable vascular implants, rising adoption of advanced stent technologies, increasing healthcare investments in interventional devices. Major trends in the forecast period include increasing adoption of nitinol-based stent designs, rising demand for minimally invasive vascular procedures, growing use of self-expanding stents in peripheral interventions, expansion of drug-compatible stent platforms, enhanced focus on long-term vessel patency.
The increasing incidence of cardiovascular diseases is expected to drive the growth of the self-expanding stents market. Cardiovascular diseases are conditions that affect the heart and blood vessels, and their rising prevalence is largely attributed to factors such as obesity, an aging population, and genetic predispositions. Self-expanding stents are effective in treating cardiovascular disorders, offering minimally invasive therapeutic options for both urgent and long-term patient needs. For example, in September 2024, data from the British Heart Foundation, a UK-based cardiovascular research organization, revealed that approximately 7.6 million people in the UK are affected by heart and circulatory diseases. This includes around 4 million men and 3.6 million women living with these conditions. Cardiovascular diseases account for about 27% of all deaths in the UK, leading to over 170,000 deaths annually-roughly 480 deaths per day, or one death every three minutes. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the self-expanding stents market.
Major companies in the self-expanding stent market are focusing on developing advanced solutions, such as drug-eluting and bioresorbable stents, to enhance vessel patency, reduce restenosis, and improve patient outcomes. Drug-eluting stents gradually release medication to prevent arterial re-narrowing, while bioresorbable stents are designed to dissolve over time after maintaining vessel openness. For instance, in June 2024, Koninklijke Philips N.V., a Netherlands-based health technology company, launched the Duo Venous Stent System in the U.S. to treat patients with venous blockages, specifically addressing symptomatic venous outflow obstruction in chronic venous insufficiency (CVI). The system includes two self-expanding stents-Duo Hybrid and Duo Extend-engineered to restore blood flow in blocked veins with flexibility, strength, and resistance to compression and vessel curvature. It aims to improve venous outflow in CVI patients while minimizing risks of stent fracture and corrosion.
In January 2024, Olympus Corporation, a Japan-based technology conglomerate, completed the acquisition of Taewoong Medical Co., Ltd. The undisclosed transaction was aimed at bolstering Olympus Corporation's gastrointestinal (GI) endotherapy product lineup and fortifying its capabilities in offering comprehensive solutions for GI treatments. Taewoong Medical Co. Ltd., based in South Korea, specializes in manufacturing self-expanding metallic stents (SEMS) for various gastrointestinal applications.
Major companies operating in the self-expanding stents market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Becton Dickinson And Company (BD Interventional), Terumo Corporation, Phenox GmbH, Balton Sp. z o.o., Biotronik SE And Co. KG, Merit Medical Systems Inc., Aesculap AG, MicroVention Inc., Lifetech Scientific Corporation, Cordis Corporation, Rontis Corporation, Veryan Medical Ltd., Andramed GmbH, Medinol Ltd., iVascular SLU, HEXACATH SAS, Eucatech AG, Endospan Ltd., Endo-Flex GmbH, Endocor GmbH
North America was the largest region in the self-expanding stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the self-expanding stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The self-expanding stents market consists of sales of coronary self-expanding stents, peripheral self-expanding stents, and biliary self-expanding stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Self-Expanding Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses self-expanding stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for self-expanding stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The self-expanding stents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.